Australia's largest stock trading and investment forum Australia's #1 stock forum

VLA

Click for more information

0.00%

$1.75 viralytics limited

Buy on the rumour, sell on the story?

First 34 Last

Share
Profile

Follow
F18FDG

629 Posts.

33

23/02/18

17:51

Post #: 31300000
Share

Originally posted by milward ↑

The shareholders have been sold short..
Why did'nt Viralytics wait to release the clinical data from the keynote trail before
doing an agreement with merck.
I expect the data to be released to be outstanding and that would have given viralytics a much
better bargaining position.
whereby cavatek will have multiple uses in combination.A very attractive proposition to big pharma
with pd1 inhibitors.
The acquisition agreement will be finalised by the end of june.The keynote trail data is to released
2q2018 so the shareholders will have prior knowledge before deciding which way to vote.
Is it possible now that viralytics will delay releasing the keynote trial data until after the deadline for the acquistion.
If big pharma get access to outstanding keynote trial data before the vote then maybe a bid from another party.

Expand

Buy on the rumour, sell on the story?

VLA Price at posting: $1.70 Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 64 more messages in this thread...

First 34 Last

Add VLA (ASX) to my watchlist